Search

everythinglearnresearchcommunity

for

Search:↓

Young women with PCOS have a higher risk of high blood pressure and metabolic syndrome, but these risks may decrease after age 40.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Low and ultralow doses of flutamide can cause liver damage in young women with high androgen levels, regardless of dose or birth control use, with higher risk for those with higher BMI and liver enzyme levels before treatment.

Intermittent low-dose finasteride works as well as daily use for treating excessive hair growth in women.

Caucasian and Asian women with PCOS generally show similar symptoms, except Asian women have less chest hair.

Women with PCOS who had antiandrogenic treatment before pregnancy had fewer complications than those without treatment.

Reproductive gynecologists are the main referrers for male infertility evaluations in North America.

Teens with PCOS and a mom with PCOS have higher insulin resistance and lower adiponectin levels, which could signal early metabolic problems.

Pioglitazone improved insulin sensitivity and altered cortisol metabolism in PCOS patients.

People with hair loss may have different levels of certain hormones due to changes in hormone processing.

Most patients improved with oral contraceptives, but some needed additional treatment.

The oral glucose tolerance test is effective in detecting abnormal glucose tolerance in Indian women with PCOS.

A blood test level of 3.2 ng/mL of Antimüllerian hormone is good for identifying polycystic ovarian morphology in European women aged 25–45.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

A woman developed male traits from accidental contact with her husband's testosterone gel.

The N363S gene variant does not cause higher adrenal androgen levels in women with polycystic ovary syndrome.

Flutamide combined with a low-dose birth control pill effectively reduces excessive hair growth in women with polycystic ovarian disease.

The combination therapy reduced hirsutism in women with PCOD and was well-tolerated.

Larger ovarian size is linked to higher insulin resistance in women with PCOS.

Cimetidine did not reduce hair growth in women with hirsutism.

Ketoconazole can treat ovarian hyperandrogenism but should be used cautiously with monitoring and birth control.

Metformin works better for adolescent girls with PCOS who have certain genetic variations.

Changing the diagnosis criteria for PCOS might miss women at risk for related health issues.

Some patients with high prolactin levels don't show symptoms because they have a form of the hormone that's less active.

Higher insulin levels are linked to larger ovaries in women with idiopathic hirsutism.

Spironolactone plus finasteride works better for treating hirsutism.

Topical finasteride doesn't reduce DHT levels, hinting at an endocrine role in hair loss.

Patients with PCOS tend to score their hirsutism higher than clinicians, making self-scoring less useful for diagnosis.

Women with acne have lower levels of a specific hormone marker than women without acne.

Treatments for enlarged prostate can cause problems with ejaculation, and less invasive options might preserve sexual function better.